GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BPH Global Ltd (ASX:BP8) » Definitions » Institutional Ownership

BPH Global (ASX:BP8) Institutional Ownership : 0.20% (As of Jun. 09, 2024)


View and export this data going back to 2000. Start your Free Trial

What is BPH Global Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BPH Global's institutional ownership is 0.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BPH Global's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BPH Global's Float Percentage Of Total Shares Outstanding is 0.00%.


BPH Global Institutional Ownership Historical Data

The historical data trend for BPH Global's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BPH Global Institutional Ownership Chart

BPH Global Historical Data

The historical data trend for BPH Global can be seen below:

2008-07-31 2008-08-31 2008-09-30 2008-10-31 2008-11-30 2008-12-31 2009-01-31 2009-02-28 2009-03-31 2009-04-30
Institutional Ownership 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20

BPH Global Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


BPH Global (ASX:BP8) Business Description

Traded in Other Exchanges
N/A
Address
96 Elizabeth Street, Block Arcade, Office 324, Level 3, Melbourne, VIC, AUS, 3000
BPH Global Ltd, formerly Stemcell United Ltd is a marine and agricultural biotechnology industry. Its only operating segment is sourcing, producing, marketing, and selling traditional medicines. The company's geographical segment includes Australia; Singapore; Malaysia and Greater China. The company's product comprises Cannabis sativa; Dendrobium Officinale and Daemonorops Draco Blume.

BPH Global (ASX:BP8) Headlines

No Headlines